Substance / Medication

Noretynodrel

Overview

Active Ingredient
norethynodrel
RxNorm CUI
7515

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

4 trials linked to this intervention

4
Total Trials
1
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Hydrosalpinx treatment before in-vitro fertilization: systematic review and network meta-analysis.
Pérez-Milán F, Caballero-Campo M, Carrera-Roig M et al. · Ultrasound Obstet Gynecol · 2025
PMID: 38764191Meta-AnalysisFull text (PMC)
Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials.
Conforti Alessandro, Carbone Luigi, Di Girolamo Raffaella et al. · Fertil Steril · 2025
PMID: 39332623Meta-Analysis
Maternal and perinatal outcomes of live births after uterus transplantation: A systematic review.
Brännström Mats, Bokström Hans, Hagberg Henrik et al. · Acta Obstet Gynecol Scand · 2025
PMID: 39579025Meta-AnalysisFull text (PMC)
Medical treatment before in-vitro fertilization in patients with adenomyosis: a systematic review and meta-analysis.
Galati Giulia, Olivieri Carlotta, Cosentino Martina et al. · J Assist Reprod Genet · 2025
PMID: 39666211Meta-AnalysisFull text (PMC)
Prevalence of contrast intravasation in HyCoSy/HyFoSy. Results of a multicenter study and systematic review of the literature with meta-analysis.
Alcazar Juan Luis, Peñate Laura, Casanova Virgina et al. · Eur J Obstet Gynecol Reprod Biol · 2025
PMID: 39673914Meta-Analysis
Progestogens for endometrial protection in combined menopausal hormone therapy: A systematic review.
Stute Petra, Walker Linus Josef, Eicher Astrid et al. · Best Pract Res Clin Endocrinol Metab · 2024
PMID: 37634998Meta-Analysis
Metformin and progestins in women with atypical hyperplasia or endometrial cancer: systematic review and meta-analysis.
Adamyan Leila, Pivazyan Laura, Isaeva Sapiyat et al. · Arch Gynecol Obstet · 2024
PMID: 38503850Meta-Analysis
Factors associated with interobserver variation amongst pathologists in the diagnosis of endometrial hyperplasia: A systematic review.
McCoy Chloe A, Coleman Helen G, McShane Charlene M et al. · PLoS One · 2024
PMID: 38683770Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Noretynodrel (substance)
SNOMED CT
126107003
UMLS CUI
C0028360
RxNorm CUI
7515

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

2
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
4
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.